Antimicrobial Susceptibilities of Group B Streptococci Isolated between 1992 and 1996 from Patients with Bacteremia or Meningitis | Zendy

Marisol Fernández | Zendy; Melissa E. Hickman | Zendy; Carol J. Baker | Zendy

Open Access

Antimicrobial Susceptibilities of Group B Streptococci Isolated between 1992 and 1996 from Patients with Bacteremia or Meningitis

Author(s) -

Marisol Fernández,

Melissa E. Hickman,

Carol J. Baker

Publication year - 1998

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.42.6.1517

Subject(s) - clindamycin , penicillin , erythromycin , microbiology and biotechnology , bacteremia , meningitis , group b , antimicrobial , group a , medicine , streptococcus agalactiae , streptococcus , streptococcus pyogenes , antibiotics , biology , bacteria , staphylococcus aureus , surgery , genetics

In vitro testing of 229 group B streptococcal isolates from a variety of patients with invasive infections indicated uniform penicillin G susceptibility. However, 17 (7.4%) isolates were resistant to erythromycin and 8 (3.4%) were resistant to clindamycin. These results support the continued use of penicillin G as the drug of choice for the treatment and prevention of group B streptococcal disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research